13 results
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:17pm
amounts of money to injured patients, delay, negatively impact or end our opportunity to receive or maintain regulatory approval to market our product
424B5
ZYME
Zymeworks Inc.
3 May 24
Prospectus supplement for primary offering
4:11pm
litigation, require us to pay substantial amounts of money to injured patients, delay, negatively impact or end our opportunity to receive or maintain
424B5
bty3 hbw9bac8
8 May 23
Prospectus supplement for primary offering
5:19pm
424B5
i7nqzau
8 May 23
Prospectus supplement for primary offering
5:18pm
424B5
4judqcs yllku9i
9 Nov 22
Prospectus supplement for primary offering
4:29pm
10-Q
rxv551d626
8 Nov 22
Quarterly report
4:09pm
424B5
xwzb3wggq fegfw7
21 Oct 22
Prospectus supplement for primary offering
4:16pm
424B5
5wq3icpksudy3pq3
13 Oct 22
Prospectus supplement for primary offering
4:56pm
- Prev
- 1
- Next